The bcr gene in Philadelphia chromosome positive acute lymphoblastic leukemia. 1989

N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
Section of Molecular Genetics, Children's Hospital of Los Angeles, CA 90027.

In chronic myelogenous leukemia (CML) and in a percentage of childhood and adult acute lymphoblastic leukemia (ALL) the Philadelphia (Ph') chromosome is present in the leukemic cells of patients. This chromosome is the result of a reciprocal translocation between chromosomes 9 and 22. In CML the break on chromosome 22 occurs within the major breakpoint cluster region (Mbcr) of the bcr gene. In this study, we report on the examination of DNAs from nine Ph'-chromosome positive ALL patients for rearrangements within the bcr gene using Southern blot analysis. Of nine patients having a karyotypically identifiable Ph'-chromosome, only five exhibited rearrangements of the bcr gene. This could indicate that in ALL, chromosome 22 sequences other than the bcr gene are involved in the Ph'-translocation. Within the group of Ph'-positive ALL patients having a bcr gene breakpoint, a correlation appears to exist between the age of the patient and the location of the breakpoint within the gene: all or the vast majority of pediatric patients analyzed to date do not have a Mbcr breakpoint as found in CML and in adult ALL.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010677 Philadelphia Chromosome An aberrant form of human CHROMOSOME 22 characterized by translocation of the distal end of chromosome 9 from 9q34, to the long arm of chromosome 22 at 22q11. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia (LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE). Ph1 Chromosome,Ph 1 Chromosome,1 Chromosomes, Ph,Chromosome, Ph 1,Chromosome, Ph1,Chromosome, Philadelphia,Chromosomes, Ph 1,Chromosomes, Ph1,Ph 1 Chromosomes,Ph1 Chromosomes
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
October 1988, Leukemia,
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
February 2022, Cancer science,
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
December 2015, Hematology (Amsterdam, Netherlands),
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
February 1993, Hematology/oncology clinics of North America,
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
October 2009, Hematology/oncology clinics of North America,
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
June 2022, The New England journal of medicine,
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
September 2015, Annals of laboratory medicine,
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
June 1989, Proceedings of the National Academy of Sciences of the United States of America,
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
July 1980, Blood,
N Heisterkamp, and R Jenkins, and S Thibodeau, and J R Testa, and K Weinberg, and J Groffen
May 1993, Blood,
Copied contents to your clipboard!